Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the Europ
about
Radiomics: extracting more information from medical images using advanced feature analysisFalse Discovery Rates in PET and CT Studies with Texture Features: A Systematic ReviewPrognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-AnalysisThe role of [¹⁸F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumorsImaging-based tumor treatment response evaluation: review of conventional, new, and emerging conceptsPrimary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysisEvaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response.Prognostic significance of (18)FDG PET/CT in colorectal cancer patients with liver metastases: a meta-analysisInternational association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma[18F]FLT and [18F]FDG PET for non-invasive treatment monitoring of the nicotinamide phosphoribosyltransferase inhibitor APO866 in human xenograftsMetabolic burden measured by (18)f-fluorodeoxyglucose positron emission tomography/computed tomography is a prognostic factor in patients with small cell lung cancerPositron emission tomography/computerized tomography in lung cancer.Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer.Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology.Prognostic Value of Metabolic Activity Measured by (18)F-FDG PET/CT in Patients with Advanced Endometrial CancerPrognostic factors in resected lung carcinomas.Maximum standardized uptake value on FDG-PET predicts survival in stage I non-small cell lung cancer following carbon ion radiotherapy.The role of metabolic tumor volume (MTV) measured by [18F] FDG PET/CT in predicting EGFR gene mutation status in non-small cell lung cancerTexture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage.Absence of a relationship between tumor ¹⁸F-fluorodeoxyglucose standardized uptake value and survival in patients treated with definitive radiotherapy for non-small-cell lung cancerLocoregional tumor failure after definitive radiation for patients with stage III non-small cell lung cancer.[¹⁸F]FDG positron emission tomography within two weeks of starting erlotinib therapy can predict response in non-small cell lung cancer patientsUtility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.Real-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation.Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour.Feasibility of cetuximab and chemoradiotherapy combination in Chinese patients with unresectable stage III non-small cell lung cancer: a preliminary reportMetabolic response assessment with (18)F-FDG PET/CT: inter-method comparison and prognostic significance for patients with non-small cell lung cancer.Early Change in Metabolic Tumor Heterogeneity during Chemoradiotherapy and Its Prognostic Value for Patients with Locally Advanced Non-Small Cell Lung Cancer.Diagnostic accuracy of contrast-enhanced computed tomography and positron emission tomography with 18-FDG in identifying malignant solitary pulmonary nodulesOptimal Scan Time of 18F-FDG PET in Identifying Therapeutic Efficacy Secondary to Radiofrequency Ablation of Lung Cancer: Case Report.Clinical Correlation Between Tumor Maximal Standardized Uptake Value in Metabolic Imaging and Metastatic Tumor Characteristics in Advanced Non-small Cell Lung Cancer.Prognostic value of the standardized uptake value for (18)F-fluorodeoxyglucose in patients with stage IIIB melanomaResponse assessment using 18F-FDG PET early in the course of radiotherapy correlates with survival in advanced-stage non-small cell lung cancerCorrelation between early 18F-FDG PET/CT response to BRAF and MEK inhibition and survival in patients with BRAF-mutant metastatic melanomaThe role of positron emission tomography/CT imaging in head and neck cancer patients after radical chemoradiotherapy.Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients.Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancerPrognostic value of (18)F-fluorodeoxyglucose positron emission tomography, computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with pathologically positive neck lymph node
P2860
Q23760733-4036D4F9-F48C-4188-8198-D65022E9CD78Q24288664-51633B81-2E37-495B-A18D-DE87CD510AB7Q26771327-451724B5-A504-49D6-96FE-0A4518B9787CQ26823482-FAB419E6-12A7-40C1-9562-B5034F917C7CQ26863654-B673B9EB-C1AA-422E-85DB-07A418953637Q27003737-57A339BE-6A48-4368-9280-5AD8A0BCE275Q27025828-08505E70-4CB2-4EEA-B0DF-D04C2A575D6BQ27851728-848D832B-A395-40E3-9CFB-2F5C7AAC7237Q28081159-175F53E9-34C2-4699-8BE7-8A61369BFE0FQ28303718-AE967682-96BC-4B18-BB62-132BCE2D6EA7Q28484852-F779DA73-13F0-4BE7-80CC-0A8C58284F79Q33619243-E8B1D375-AAEC-4EA1-8EEF-88ED60FD8F78Q33657999-6102C419-0F2C-40EF-94B3-7D667FD5FBB5Q33669810-8DC5C1CB-4DB2-4E62-B5AF-0B1795D53F71Q33669828-B397F2F2-7780-48B6-AAD2-B0306925AFE5Q33669870-E8DF66C9-182E-423E-B8B1-54AAF55B1304Q33697964-9B72FEC6-7D11-4571-A009-FDAA7654C2CCQ33750851-0F952B88-84E3-46DA-B52F-80A241A2A52DQ33779663-6D9A1516-D49E-4969-92F7-9951FE3568FEQ33994286-9F0A5151-EAED-408D-AE56-778C897671D1Q34041796-6B56C7CE-C7E0-4521-B422-B04E9BBECF58Q34135928-6EF6B8E8-C49F-41F4-B336-5DCB5D6E0FDFQ35088202-4D280FE8-EA96-4737-9A6E-039F3082D4DCQ35131272-C38D546B-3B72-43B0-888D-15BB75A87D8AQ35167410-77DEB46C-ECDE-4E29-86B7-2FD4E81821FFQ35201548-AF70F45A-B956-4049-8C0A-32E789574163Q35538759-CAEC1444-F68D-40A8-BB8B-FD1E13709D4DQ36024114-0BD43C49-8FE1-4755-BC76-CCEAD1585F21Q36056706-5654DC99-C7D2-4A05-A9FB-8C66FA7B412FQ36151227-A6992AEC-0D66-4C02-AB7C-9F76705C4E36Q36194533-F559F6D5-2C94-4226-B542-5A2E2FFFFFC5Q36195043-14F07D45-8347-47E4-A5C0-68AFEF4FFC38Q36279410-3229B61F-411C-49D2-BDCB-E094596C4E24Q36341962-4185BA0B-6672-4995-BC10-922F6EA4944BQ36399789-C69C9FB8-0111-46AF-9968-8ECDBB657200Q36407111-75A395B2-0F4F-4253-AEF4-E61407B5B5DBQ36425348-9EE1C91F-C5CB-4425-A2D0-BD08710BDACAQ36490370-1EB8879D-2152-4593-9A41-A2242EBD914DQ36516767-88BE738B-5466-40AD-9F92-D3B9E4E61247Q36537056-14B800E1-AED7-408A-A0F7-34971D9F1121
P2860
Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the Europ
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Primary tumor standardized upt ...... eta-analysis (MA) by the Europ
@en
Primary tumor standardized uptake value
@nl
type
label
Primary tumor standardized upt ...... eta-analysis (MA) by the Europ
@en
Primary tumor standardized uptake value
@nl
prefLabel
Primary tumor standardized upt ...... eta-analysis (MA) by the Europ
@en
Primary tumor standardized uptake value
@nl
P2093
P1476
Primary tumor standardized upt ...... LC Lung Cancer Staging Project
@en
P2093
Anne-Pascale Meert
Arnaud Scherpereel
Catherine Castaigne
Claude Hossein-Foucher
Céline Mascaux
Edward F Patz
European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project
Jean-Jacques Lafitte
Jean-Paul Sculier
Marianne Paesmans
P356
10.1097/JTO.0B013E31815E6D6B
P50
P577
2008-01-01T00:00:00Z